Jorey Chernett
Jorey Chernett's purchase track record
How the stock did after each of Jorey Chernett's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/14/2026 | STLN | $78K | pending | pending | — |
| 8/14/2026 | STIM | $44K | pending | pending | — |
| 7/21/2026 | STLN | $95K | pending | pending | — |
| 7/14/2026 | STIM | $62K | +12.4% | pending | — |
| 7/10/2026 | STLN | $88K | pending | pending | — |
| 6/23/2026 | STLN | $90K | pending | pending | — |
| 5/12/2026 | STIM | $754K | +151.2% | pending | — |
| 4/20/2026 | STIM | $309K | +27.9% | pending | — |
| 4/14/2026 | AIRS | $154K | +60.3% | -38.2% | +12.0% |
| 4/3/2026 | AIRS | $430K | +44.5% | -42.9% | +16.8% |
| 3/25/2026 | STIM | $1.37M | -10.0% | +105.7% | +16.9% |
| 3/19/2026 | AIRS | $461K | +81.6% | -15.4% | +15.6% |
| 3/17/2026 | STIM | $2.27M | -2.0% | +128.6% | +13.0% |
| 3/11/2026 | AIRS | $659K | +119.9% | +15.5% | +12.7% |
| 3/3/2026 | AIRS | $284K | +200.9% | +39.8% | +11.9% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
Starling Oncology reports stronger cash flow and gross profit. Starling Oncology disclosed higher cash flow and gross profit in its latest results. The improvement has prompted analysts to consider a re‑rating of the stock. The company’s financial metrics are now better positioned relative to its recent price range.
Transaction History
| STIM | ▲ Buy | Open Market | 14,000 | $44K | 8/14/2026 | View on chart |
| STLN | ▲ Buy | Open Market | 12,000 | $78K | 8/14/2026 | View on chart |
| STLN | ▲ Buy | Open Market | 18,000 | $95K | 7/21/2026 | View on chart |
| STIM | ▲ Buy | Open Market | 35,000 | $62K | 7/14/2026 | View on chart |
| STLN | ▲ Buy | Open Market | 15,000 | $88K | 7/10/2026 | View on chart |
| STLN | ▲ Buy | Open Market | 18,000 | $90K | 6/23/2026 | View on chart |
| STLN | ▲ Buy | Open Market | 12,000 | $57K | 6/4/2026 | View on chart |
| STLN | ▲ Buy | Open Market | 33,500 | $136K | 5/20/2026 | View on chart |
| STIM | ▲ Buy | Open Market | 100,000 | $117K | 5/19/2026 | View on chart |
| STLN | ▲ Buy | Open Market | 5,000 | $20K | 5/19/2026 | View on chart |
| STLN | ▲ Buy | Open Market | 30,000 | $123K | 5/19/2026 | View on chart |
| STIM | ▲ Buy | Open Market | 475,000 | $637K | 5/12/2026 | View on chart |
| STIM | ▲ Buy | Open Market | 100,000 | $151K | 4/21/2026 | View on chart |
| STIM | ▲ Buy | Open Market | 100,000 | $158K | 4/20/2026 | View on chart |
| AIRS | ▲ Buy | Open Market | 40,000 | $102K | 4/17/2026 | View on chart |
| AIRS | ▲ Buy | Open Market | 20,000 | $52K | 4/14/2026 | View on chart |
| STLN | ▲ Buy | Open Market | 20,000 | $62K | 4/9/2026 | View on chart |
| AIRS | ▲ Buy | Open Market | 60,000 | $176K | 4/7/2026 | View on chart |
| AIRS | ▲ Buy | Open Market | 90,000 | $254K | 4/3/2026 | View on chart |
| STIM | ▲ Buy | Open Market | 385,442 | $482K | 3/30/2026 | View on chart |
| STIM | ▲ Buy | Open Market | 500,000 | $675K | 3/27/2026 | View on chart |
| STLN | ▲ Buy | Open Market | 27,429 | $81K | 3/27/2026 | View on chart |
| STIM | ▲ Buy | Open Market | 25,000 | $36K | 3/26/2026 | View on chart |
| STLN | ▲ Buy | Open Market | 50,000 | $158K | 3/26/2026 | View on chart |
| STIM | ▲ Buy | Open Market | 125,000 | $175K | 3/25/2026 | View on chart |
| STLN | ▲ Buy | Open Market | 125,000 | $389K | 3/24/2026 | View on chart |
| AIRS | ▲ Buy | Open Market | 50,000 | $146K | 3/23/2026 | View on chart |
| AIRS | ▲ Buy | Open Market | 40,000 | $111K | 3/20/2026 | View on chart |
| STIM | ▲ Buy | Open Market | 169,472 | $239K | 3/20/2026 | View on chart |
| STLN | ▲ Buy | Open Market | 25,000 | $84K | 3/20/2026 | View on chart |
| AIRS | ▲ Buy | Open Market | 77,702 | $205K | 3/19/2026 | View on chart |
| STIM | ▲ Buy | Open Market | 450,000 | $599K | 3/19/2026 | View on chart |
| STIM | ▲ Buy | Open Market | 607,400 | $820K | 3/18/2026 | View on chart |
| AIRS | ▲ Buy | Open Market | 83,000 | $212K | 3/17/2026 | View on chart |
| STIM | ▲ Buy | Open Market | 531,000 | $616K | 3/17/2026 | View on chart |
| STLN | ▲ Buy | Open Market | 75,000 | $257K | 3/17/2026 | View on chart |
| AIRS | ▲ Buy | Open Market | 105,848 | $257K | 3/16/2026 | View on chart |
| STLN | ▲ Buy | Open Market | 60,985 | $201K | 3/16/2026 | View on chart |
| STLN | ▲ Buy | Open Market | 263,000 | $768K | 3/13/2026 | View on chart |
| AIRS | ▲ Buy | Open Market | 88,000 | $189K | 3/11/2026 | View on chart |
| AIRS | ▲ Buy | Open Market | 45,600 | $91K | 3/6/2026 | View on chart |
| AIRS | ▲ Buy | Open Market | 30,000 | $56K | 3/4/2026 | View on chart |
| AIRS | ▲ Buy | Open Market | 80,000 | $137K | 3/3/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
STIM shifts focus from devices to psychedelic infrastructure
Neuronetics announced it is moving away from solely manufacturing its TMS device and is building a platform to support psychedelic therapies. The change aims to broaden the company's role in the emerging mental-health market. The stock is currently trading near its $1.19 support level and has an RSI of 25.4, indicating a low momentum environment.
STIM shifts focus from devices to psychedelic infrastructure. Neuronetics announced it is moving away from solely manufacturing its TMS device and is building a platform to support psychedelic therapies. The change aims to broaden the company's role in the emerging mental-health market. The stock is currently trading near its $1.19 support level and has an RSI of 25.4, indicating a low momentum environment.